Transitional Year·Brandon, FL

HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa South/Brandon Hospital

Signal lift11%40%+29 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
241–269
p10 – p90
Sample N
652
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
1.7%
11 of 652 applicants
01Cohort funnelthis cycle
N = 652
Applied
652
100.0%
Invited
160
24.5%
Class size
11
1.7%
No visa sponsorshipGraduated within 2 yearsPreliminaryHospitalist
Your fitHCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa South/Brandon Hospital Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at HCA Florida Healthcare

Create free account

Who to contact

Training sites2 hospitals
  • 1
    HCA Florida Healthcare/USF Morsani College of Medicine GME
    Tampa, FL
    Primary
  • 2
    HCA Florida Brandon Hospital
    Brandon, FL
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK241 – 269
180205230255280
COMLEX Level 2 CE529 – 709
400500600700800
Interview rates
US MD
33%
US DO
27%
US IMG
5%
Non-US IMG
2%
Applicant origin
In-state
59%
Out-of-state
14%
Interview prepTransitional Year
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa South/Brandon Hospital to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Transitional Year.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.